Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00327067 · ClinicalTrials.gov registry record
Iron Replacement in Blood Donors
A clinical trial of Iron-deficiency, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 1,820
- Enrollment target
- 1
- Study location
NCT00327067: Completed study of Iron-deficiency, sponsored by National Institutes of Health Clinical Center (CC).
NCT00327067 is a study of Iron-deficiency that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,820 participants, above the 85-participant average among 16 other Iron-deficiency trials with a reported enrollment target (2041% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00327067, a study of Iron-deficiency, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 1,820 participants
- Enrollment target
- 1
- Study location
Study Summary
Blood donors who have a low fingerstick hemoglobin level are usually deferred from donating. A possible solution to the problem of repeated deferrals might be for Blood Banks to offer donors with low hemoglobin levels oral iron supplements. To determine the feasibility of such a program, this study will: * Determine the frequency of iron deficiency in first-time and repeat blood donors * Examine the effects of long-term blood donation on donor hemoglobin levels and iron stores * Compare body iron stores in donors who have low hemoglobin values with that of donors who have acceptable hemoglobin values at the time of donation * Determine what conditions other than iron deficiency lead to low hemoglobin levels in blood donors * Determine the safety and effectiveness of giving oral iron tablets to donors with low hemoglobin levels * Monitor the effect of oral iron administration on donor satisfaction and donor retention. First-time and repeat blood donors at the NIH Clinical Center Blood Bank 18 years of age and older may be eligible for this study. Participants include prospective donors who have an acceptable hemoglobin value at the time of donation and those whose hemoglobin level is determined to be too low for donation. All participants do the following: * Answer medical questions about their diet, health, and family history of blood disorders. * Have blood samples drawn from their arm for testing blood cell counts, iron stores, and other hemoglobin-related tests as appropriate. Donors with low hemoglobin also: * Take iron supplements (ferrous sulfate) to replenish iron stores. (Donors who have previously had unpleasant side effects from ferrous sulfate are offered ferrous gluconate as an alternative.) * Undergo evaluation with medical screening and laboratory tests at the time of future blood donations.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,820 participants |
| Start Date | 2006-05-12 |
| Est. Completion | 2012-03-01 |
What the finished NCT00327067 record still lists
NCT00327067 is an observational study that tracks outcomes without assigning an intervention. Its 1,820 participants enrollment target places it among the larger protocols in the corpus, above the 85-participant average among 16 other Iron-deficiency trials with a reported enrollment target (2041% higher).
The record links to 1 condition, with Iron-deficiency appearing as the primary indexed condition, and to 0 interventions.
NCT00327067 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00327067 about?
NCT00327067 is a clinical study titled "Iron Replacement in Blood Donors". Blood donors who have a low fingerstick hemoglobin level are usually deferred from donating. A possible solution to the problem of repeated deferrals might be for Blood Banks to offer donors with low hemoglobin levels oral iron supplements. To determine the feasibility of such a program, this study ...
What is the current status of trial NCT00327067?
This trial is currently completed. The enrollment target is 1,820 participants. The study started on 2006-05-12. Estimated completion is 2012-03-01.
What conditions does trial NCT00327067 study?
This clinical trial studies the following conditions: Iron-deficiency.
Who is sponsoring clinical trial NCT00327067?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00327067 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Iron-deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00327067's enrollment target sits among peer trials
1,820 1st of 16 higher than 16 of 16 other Iron-deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Iron-deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
RECRUITING · Phase 2
-
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
RECRUITING · Phase 4
-
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
RECRUITING · Phase 4
-
IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
RECRUITING · Phase 2
-
A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women
COMPLETED · NA
-
Effect of Iron Supplements on the Growth of Enteric Pathogens
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI